Related Experiment Video
Updated: Apr 18, 2026
07:12
Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
5.3K
Hypoparathyroidism: a brief historical overview for clinicians
Juan J Díez1,2,3
1Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain.
Frontiers in Endocrinology
|April 17, 2026
Summary
Hypoparathyroidism, a rare endocrine disorder of parathyroid hormone (PTH) deficiency, historically lacked hormone replacement. Recent advances now enable physiological treatments for improved mineral metabolism.
Area of Science:
- Endocrinology
- Mineral Metabolism
- Medical History
Background:
- Hypoparathyroidism (HP) is a rare endocrine disorder caused by deficient parathyroid hormone (PTH) secretion, leading to hypocalcemia and hyperphosphatemia.
- Etiologies are diverse, including postsurgical, genetic, autoimmune, and infiltrative causes.
- Historically, HP management focused on calcium and vitamin D, lacking effective PTH replacement therapies.
Purpose of the Study:
- To provide a historical review of hypoparathyroidism (HP) evolution.
- To highlight key milestones in understanding parathyroid physiology and mineral homeostasis.
- To discuss the transition towards physiological hormone replacement therapies.
Main Methods:
- Literature review of historical and recent scientific publications.
- Analysis of advancements in molecular biology, diagnostics, and therapeutics.
- Examination of the development of parathyroid hormone (PTH) based treatments.
Main Results:
- Elucidation of calcium/phosphate regulation, PTH function, calcium-sensing receptor, and FGF23/klotho pathways.
- Improved diagnostic accuracy through advancements in clinical chemistry for calcium and PTH measurement.
- Development of recombinant PTH, prodrugs, and receptor agonists transforming treatment landscape.
Conclusions:
- Hypoparathyroidism management is evolving from conventional treatments to physiological hormone replacement.
- Emerging therapies like oral agents and cell-based strategies promise improved long-term outcomes.
- A new era of managing HP focuses on restoring mineral metabolism and enhancing patient well-being.
Related Concept Videos
00:59The Parathyroid Glands
6.2K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
6.2K
01:27Hyperthyroidism II: Pathophysiology
6
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
6
01:23Hypothyroidism II: Pathophysiology
4
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
4
01:25Hyperthyroidism I: Introduction
4
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
4
01:24Graves Disease II: Pathophysiology
5
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
5
01:28Graves' Disease I: Introduction
4
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
4